Fielmann AG (FIE.DE)
Fielmann AG operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Hamburg, HA, DE. The stock last traded at $40.70, down 1.45% on the session, giving a market capitalisation of $3.42B. Its beta of 0.61 implies it has historically moved less than the broad market.
Through its subsidiaries, Fielmann Aktiengesellschaft focuses on investing in and managing businesses within the optics and hearing aid sectors. It produces and distributes an extensive array of visual aids, such as spectacles, frames, lenses, sunglasses, contact lenses, and related accessories. In addition to these optical offerings, Fielmann provides hearing aids, their accompanying accessories, and diverse general merchandise. By the close of 2021, its retail footprint encompassed 693 stores, predominantly in Germany (610), along with significant operations in Spain (87), Italy (43), Switzerland (45), Austria (38), Poland (37), Slovenia (32), Luxembourg (3), and an additional 15 outlets scattered across other European nations. An additional 78 smaller establishments are maintained throughout Eastern Europe. Its product range is also available for purchase via its digital storefronts. Founded in 1972, the firm's headquarters are situated in Hamburg, Germany. Fielmann Aktiengesellschaft operates as a subsidiary of Korva SE.
Fielmann AG is most often compared with the following Healthcare names: